Učitavanje...
Prostate-Specific Antigen Nadir Within 12 Months of Prostate Cancer Radiotherapy Predicts Metastasis and Death
BACKGROUND: The nadir prostate-specific antigen (PSA) at 1 year (nPSA12) was investigated as an early estimate of biochemical and clinical outcome after radiotherapy (RT) alone for localized prostate cancer. METHODS: From May 1989 to November 1999, 1000 men received 3D conformal RT alone (median, 76...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2007
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1892752/ https://ncbi.nlm.nih.gov/pubmed/17133416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.22341 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|